1. YOUNG HIGH RISK PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDING BCL‐2/MYC DOUBLE HIT LYMPHOMAS BENEFIT FROM DOSE‐DENSE IMMUNOCHEMOTHERAPY WITH EARLY CNS PROPHYLAXIS. (12th June 2019) Authors: Leppä, S.; Jørgensen, J.; Tierens, A.; Meriranta, L.; Østlie, I.; Brown, P.; Fagerli, U.; Larsen, T.S.; Mannisto, S.; Munksgaard, L.; Maisenhølder, M.; Vasala, K.; Meyer, P.; Jerkeman, M.; Björkholm, M.; Fluge, Ø.; Jyrkkiö, S.; Ralfkiaer, E.; Spetalen, S.; Karjalainen‐Lindsberg, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗